The Future of IBD Treatment in APAC: Biologics, JAK Inhibitors, and Emerging Therapies by Leading Companies like Merck and AbbVie
The Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market is witnessing significant growth, driven by factors such as increasing prevalence of IBD, improving healthcare infrastructure, and rising awareness among healthcare professionals and patients. Inflammatory Bowel Disease, which includes conditions like Crohn's disease and ulcerative colitis, affects millions of individuals across...
0 Σχόλια
0 Μοιράστηκε